Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Aug 21:5:199.
doi: 10.3389/fvets.2018.00199. eCollection 2018.

Evaluation of the Epithelial Barrier Function and Ileal Microbiome in an Established Necrotic Enteritis Challenge Model in Broiler Chickens

Affiliations

Evaluation of the Epithelial Barrier Function and Ileal Microbiome in an Established Necrotic Enteritis Challenge Model in Broiler Chickens

Juan D Latorre et al. Front Vet Sci. .

Abstract

Necrotic enteritis (NE) is a recognized multifactorial disease that cost annually to the poultry industry around $2 billion. However, diverse aspects related to its presentation are not completely understood, requiring further studies using known induction experimental models. Therefore, the purpose of this study was to measure the changes occurring in performance, intestinal integrity and ileal microbiome using a previously established NE-challenge model. Chickens were assigned to a negative control group (NC) or a positive control group (PC). In the PC, broilers were orally gavaged with Salmonella Typhimurium (ST) (1 × 107 cfu/chick) at day 1, Eimeria maxima (EM) (2.5 × 104 oocyst/chick) at day 18 and Clostridium perfringens (CP) (1 × 108 cfu/chick/day) at 23-24 days of age. Weekly, body weight (BW), body weight gain (BWG), feed intake (FI) and feed conversion ratio (FCR) were evaluated. Morbidity and mortality were determined throughout the study, and NE lesion scores were recorded at day 25. Additionally, blood and liver samples were collected to measure gut permeability as determined by levels of serum fluorescein isothiocyanate-dextran (FITC-d) and bacterial translocation (BT). Ileal contents were processed for 16S rRNA gene-based microbiome analysis. Performance parameters and intestinal permeability measurements were negatively impacted in the PC resulting in elevated serum FITC-d and BT with a -6.4% difference in BWG. The NE lesion score in PC (1.97 vs. 0.00) was significantly higher in comparison to NC, although there was no difference in mortality. The microbiome analysis showed a dramatic shift of ileal microbiomes in PC groups as compared to NC (ANOSIM: R = 0.76, P = 0.001). The shift was characterized by reduced abundance of the phylum Actinobacteria (P < 0.01), and increased abundance of the genera Butyrivibrio, Lactobacillus, Prevotella and Ruminococcus in PC compared to NC (P < 0.05). Expectedly, Clostridium was found higher in PC (2.98 ± 0.71%) as compared to NC (1.84 ± 0.36%), yet the difference was not significant. In conclusion, results of the present study showed the different intestinal epithelial and microbiological alterations occurring in an established NE-challenge model that considers paratyphoid Salmonella infections in young chicks as an important predisposing factor for presentation of NE.

Keywords: Clostridium perfringens; broiler chickens; intestinal permeability; microbiome; necrotic enteritis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Change in body weight gain (BWG; g/broiler) after challenge with (A) Eimeria maxima and (B) Clostridium perfringens in a Necrotic enteritis model.
Figure 2
Figure 2
Relative abundance (%) of bacteria at (A) Phylum, (B) Family, and (C) Genus levels in the ileum of negative and positive control (with induced necrotic enteritis) groups. Minor bacteria genera including unassigned values were included as “others”.
Figure 3
Figure 3
PCoA plot showing beta diversity between Negative and Positive control (with induced necrotic enteritis) as measured by weighted UniFrac metric. ANOSIM results (R = 0.76, P = 0.001) showed significant difference in community structure between groups.

References

    1. McDonel JL. Clostridium perfringens toxins (type a, b, c, d, e). Pharmacol Ther. (1980) 10:617–55. 10.1016/0163-7258(80)90031-5 - DOI - PubMed
    1. Labbe R, Huang T. Generation times and modeling of enterotoxin-positive and enterotoxin-negative strains of Clostridium perfringens in laboratory media and ground beef. J Food Protect. (1995) 58:1303–6. 10.4315/0362-028X-58.12.1303 - DOI - PubMed
    1. Uzal FA, Freedman JC, Shrestha A, Theoret JR, Garcia J, Awad MM, et al. Towards an understanding of the role of Clostridium perfringens toxins in human and animal disease. Future Microbiol. (2014) 9:361–77. 10.2217/fmb.13.168 - DOI - PMC - PubMed
    1. Williamson E, Titball RA. A genetically engineered vaccine against the alpha-toxin of Clostridium perfringens protects mice against experimental gas gangrene. Vaccine (1993) 11:1253–8. 10.1016/0264-410X(93)90051-X - DOI - PubMed
    1. Awad MM, Bryant AE, Stevens DL, Rood JI. Virulence studies on chromosomal alpha-toxin and theta-toxin mutants constructed by allelic exchange provide genetic evidence for the essential role of α -toxin in Clostridium perfringens-mediated gas gangrene. Mol Microbiol. (1995) 15:191–202. 10.1111/j.1365-2958.1995.tb02234.x - DOI - PubMed